Heart Disease Clinical Trials in Detroit

Showing 341-360 of 460 trials

Blood Collection of Patient Presenting in the ED and Prescribed a BNP

NCT02614209

Plasma specimen collected from patients presenting in the Emergency Department (ED) with or without Heart Failure (HF) and prescribed a BNP.

Heart Failure

Fujirebio Diagnostics, Inc.400 participantsStarted May 2015

Baltimore, Maryland, United States • Detroit, Michigan, United States

COMPLETEDNA< 1 mile

GORE Flow Reversal System and GORE Embolic Filter Extension Study

NCT01343667

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Carotid StenosisConstriction, PathologicCarotid Artery Diseases+8 more

W.L.Gore & Associates1,397 participantsStarted Apr 2011

Flagstaff, Arizona, United States • Newport Beach, California, United States • San Francisco, California, United States +36 more locations

Blood Collection of Patient Presenting in the ED and Prescribed a BNP

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Heart Disease Trials in Other Cities

Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial

TAXUS Libertē Post Approval Study

Niacin Plus Statin to Prevent Vascular Events

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study

Veterans Walk for Health Study

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Study of Renal Denervation in Patients With Heart Failure

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Sensor Optimization of Cardiac Resynchronization Therapy Response

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Other Conditions in Detroit